A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Sanguine Biosciences20 enrolled

Overview

The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.

Blood samples are collected in the comfort and safety of your home by a certified medical professional. We have mobile phlebotomists located in major metropolitan areas around the nation for your convenience.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Alzheimer's Disease Multiple Sclerosis Parkinson's Disease Huntington's Disease Amyotrophic Lateral Sclerosis (ALS)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Males and females \>18 to 100 years old * A diagnosis of neurological condition * Proof of diagnosis can be provided Control group: Healthy donors, males and females, 18 to 100 years of age Exclusion Criteria * Receipt of blood products within 30 days of study enrollment * Receipt of an investigational (unapproved) drug within 30 days of study enrollment

Locations (1)

Sanguine Biosciences

Sherman Oaks, California, United States

Outcomes

Primary Outcomes

Biospecimens & Clinical Data collection from patients with neurological diseases.

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.